COG-AALL05B1
Clinical Trial Title | Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens |
Trial Status | Open to Enrollment |
Start Date | 04/16/2007 |
Location | randall-childrens-hospital-at-legacy-emanuel |
Trial Type | Pediatric Cancer (Oncology) |
Specific Condition | Acute Lymphoblastic Leukemia (ALL) Relapse |
Description | This research study is collecting and storing samples of bone marrow and blood from patients with relapsed acute lymphoblastic leukemia or relapsed non-Hodgkin lymphoma. Collecting and storing samples of bone marrow and blood from patients with cancer to study in the laboratory may help doctors learn more about cancer and help predict the recurrence of cancer. |
Eligibility Criteria | Patient has ALL (or a prior history of Non-Hodgkin Lymphoma) at first or subsequent marrow relapse with greater than or equal to 25% blasts in the bone marrow and/or peripheral blood Prior enrollment in a COG ALL trial at initial diagnosis is not required Enrollment in a COG therapeutic trial at relapse is not required No systemic anti-leukemic treatment has been administered for the current relapse Patients are eligible if they have relapsed while receiving therapy |
IRB Number | |
Notes | https://clinicaltrials.gov/ct2/show/NCT00897325 |
Principal Investigator | Janice Olson, MD |
Contact Name | Children's Cancer and Blood Disorders Program |
Contact Phone | (503) 276-9300 |
Contact Fax | |
Contact E-Mail |